- Home
- JZ vs ENLV Comparison
JZ vs ENLV Comparison
Compare JZ & ENLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JZ
- ENLV
- Stock Information
- Founded
- JZ 2011
- ENLV 2005
- Country
- JZ China
- ENLV Israel
- Employees
- JZ N/A
- ENLV N/A
- Industry
- JZ Other Consumer Services
- ENLV Biotechnology: Pharmaceutical Preparations
- Sector
- JZ Real Estate
- ENLV Health Care
- Exchange
- JZ Nasdaq
- ENLV Nasdaq
- Market Cap
- JZ 1.4M
- ENLV 23.7M
- IPO Year
- JZ 2022
- ENLV 1995
- Fundamental
- Price
- JZ $1.66
- ENLV $1.54
- Analyst Decision
- JZ
- ENLV Strong Buy
- Analyst Count
- JZ 0
- ENLV 2
- Target Price
- JZ N/A
- ENLV $10.00
- AVG Volume (30 Days)
- JZ 38.6K
- ENLV 201.4K
- Earning Date
- JZ 09-26-2025
- ENLV 08-29-2025
- Dividend Yield
- JZ N/A
- ENLV N/A
- EPS Growth
- JZ N/A
- ENLV N/A
- EPS
- JZ N/A
- ENLV N/A
- Revenue
- JZ $34,090,704.00
- ENLV N/A
- Revenue This Year
- JZ N/A
- ENLV N/A
- Revenue Next Year
- JZ N/A
- ENLV N/A
- P/E Ratio
- JZ N/A
- ENLV N/A
- Revenue Growth
- JZ N/A
- ENLV N/A
- 52 Week Low
- JZ $1.39
- ENLV $0.81
- 52 Week High
- JZ $14.60
- ENLV $1.76
- Technical
- Relative Strength Index (RSI)
- JZ 34.02
- ENLV 75.52
- Support Level
- JZ $1.57
- ENLV $1.12
- Resistance Level
- JZ $1.79
- ENLV $1.32
- Average True Range (ATR)
- JZ 0.11
- ENLV 0.10
- MACD
- JZ 0.07
- ENLV 0.02
- Stochastic Oscillator
- JZ 21.95
- ENLV 77.89
About JZ Jianzhi Education Technology Group Company Limited
Jianzhi Education Technology Group Co Ltd engages in developing educational content to fulfill the massive demand for high-quality, professional development training resources in China. The company and its subsidiaries VIE and VIEs generate subscription revenue through selling subscriptions to online learning platforms, higher education institutions, and other institutional customers under a B2B2C model mainly through the platform of Sentu Academy; offering subscriptions concerning educational content in mobile video packages directly to end users under a B2C model through the platforms such as Fish Learning or Light Class, etc. It has two operating segments: Educational content services and other services and IT-related solution services.
About ENLV Enlivex Therapeutics Ltd.
Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.